Auxilart Obtains Certification for the International Standard “ISO/IEC 27001” for Information Security Management Systems

Auxilart Co., Ltd. (Headquarters: Tokyo, Japan, CEO: Junu Kim) is pleased to announce that it has obtained certification for its Information Security Management System (ISMS) in accordance with the international standard ISO/IEC 27001:2022 and the Japanese standard JIS Q 27001:2023.

This certification demonstrates that Auxilart’s information security management system has been properly established, implemented, and maintained in compliance with internationally recognized standards, as verified by an accredited third-party certification body.

Background of the Certification

Auxilart provides digital solutions centered on mechanistic modeling to support the development of pharmaceutical manufacturing processes. As collaborations with pharmaceutical-related companies progress, the importance of securely managing sensitive research data and manufacturing process information has continued to increase.

In response, Auxilart has positioned information security as a critical management priority and has systematically built and continuously improved its information security management framework. Through the acquisition of ISO/IEC 27001 certification, Auxilart’s information security management system has been formally recognized as conforming to international information security standards.

Auxilart will continue to enhance its information security practices and remain a trusted technology partner for pharmaceutical-related companies seeking reliable and secure digital solutions.

Certification Details

Certification Standard
ISO/IEC 27001:2022
JIS Q 27001:2023

Certification Registration Number
IS 835800

Scope of Certification
The development and provision of solutions for optimizing pharmaceutical manufacturing processes through the utilization of digital technology.

Statement of Applicability, issue on 14/Oct/2025, Version 1

Certification Body
BSI Group Japan K.K.

About Auxilart

Auxilart Co., Ltd. provides advanced digital simulation solutions based on mechanistic models developed at the University of Tokyo, where the technology has been developed over a decade.

Our Mechanistic model-based simulation technology enables high-precision simulations with minimal data, using only 1% of the data typically required by AI-based methods. By replacing extensive physical experiments with digital simulations, we achieve up to 90% reduction in both cost and time while enhancing productivity.

Founded in 2023, Auxilart has already provided its solutions to Boehringer Ingelheim and major Japanese pharmaceutical companies.

For more information, visit Auxilart's Website.

Media Contact

Auxilart Inc.
Established: July 19, 2023
CEO: Junu Kim
Headquarters: 6F, 1-12-4 Ginza, Chuo-ku, Tokyo, Japan

Contact Person: Kay (Keisuke) Okita
LinkedIn: linkedin.com/company/auxilart-co-ltd/
Email: information@auxilart.com